CD8A and melanoma: The “dual-sugar”-based vaccine preparation promoted antigen uptake by and maturation of bone-marrow-derived dendritic cells, enhanced the CD8+ response in vivo which led to a potent reduction of tumor burden in a mouse melanoma model.